Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1750 of 2228 entries
View as:

Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT00909038 Org: User:
Start: 05/31/09 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Administered to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02211924 Org: User:
Start: 08/31/07 End: - Due: -

Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01309139 Org: User:
Start: 03/31/11 End: - Due: -

Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals With COPD

Phase: N/A Priority: Normal
NCT ID: NCT04795323 Org: User:
Start: 04/08/21 End: 03/12/22 Due: 03/12/23

Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02265653 Org: User:
Start: 11/30/99 End: - Due: -

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT02244281 Org: User:
Start: 05/31/01 End: - Due: -

Dabigatran Etexilate in Patients With Mechanical Heart Valves

Phase: N/A Priority: Normal
NCT ID: NCT01452347 Org: User:
Start: 10/31/11 End: 06/30/13 Due: 06/30/14

Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02176187 Org: User:
Start: 04/30/03 End: - Due: -

Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02096744 Org: User:
Start: 03/31/14 End: 06/30/14 Due: 06/30/15

CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01243424 Org: User:
Start: 11/11/10 End: 08/21/18 Due: 08/21/19

To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706

Phase: N/A Priority: Normal
NCT ID: NCT01763333 Org: User:
Start: 01/08/13 End: 09/04/13 Due: 09/04/14

Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01734785 Org: User:
Start: 02/08/13 End: 03/23/15 Due: 03/23/16

Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02201329 Org: User:
Start: 08/31/14 End: 09/30/15 Due: 09/30/16

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

Phase: N/A Priority: Normal
NCT ID: NCT00881530 Org: User:
Start: 03/31/09 End: - Due: -

Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02209792 Org: User:
Start: 10/31/01 End: - Due: -

A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04899674 Org: User:
Start: 06/30/21 End: 09/02/21 Due: 09/02/22

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05965583 Org: User:
Start: 08/02/23 End: 10/24/23 Due: 10/24/24

Safety and Tolerability of BI 685509 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03116906 Org: User:
Start: 04/24/17 End: 06/01/18 Due: 06/01/19

A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

Phase: N/A Priority: Normal
NCT ID: NCT03835481 Org: User:
Start: 03/18/19 End: 07/27/21 Due: 07/27/22

Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus

Phase: N/A Priority: Normal
NCT ID: NCT02254044 Org: User:
Start: 10/31/03 End: - Due: -

Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression

Phase: N/A Priority: Normal
NCT ID: NCT02229825 Org: User:
Start: 02/09/07 End: 08/26/08 Due: 08/26/09

Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00333411 Org: User:
Start: 06/30/06 End: - Due: -

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Phase: N/A Priority: Normal
NCT ID: NCT00148486 Org: User:
Start: 06/30/03 End: - Due: -

Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259998 Org: User:
Start: 10/31/01 End: - Due: -

An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01206816 Org: User:
Start: 10/04/10 End: 11/15/12 Due: 11/15/13